LIfT BioSciences Company

LIfT BioSciences is a socially-minded Biotech start-up developing a portfolio of potentially life-saving immuno-oncology cell therapies for different solid tumours using its innate immunity platform, known as Leukocyte Infusion Therapy (LIfT). LIfT BioSciences Ltd was set-up with Prof Zhen Cui of Wake Forest University, a leading pioneer in LIFT, following his discovery of a cancer resistant (SR/CR) mouse that proved to have transferable innate immunity. The goal is to create a Cell Bank with the potential to cure cancer, using Leukocyte Infusion Therapy (LIfT).
Technology: Cell Therapies
Industry: Personalized Medicine
Headquarters: London, England, United Kingdom
Founded Date: 2016
Employees Number: Undisclosed
Funding Status: Seed

Visit Website
Register and Claim Ownership